These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 26882530

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.
    Wang C, Hou H, Nan K, Sailor MJ, Freeman WR, Cheng L.
    Exp Eye Res; 2014 Dec; 129():74-82. PubMed ID: 25446320
    [Abstract] [Full Text] [Related]

  • 3. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
    Hou H, Nieto A, Ma F, Freeman WR, Sailor MJ, Cheng L.
    J Control Release; 2014 Mar 28; 178():46-54. PubMed ID: 24424270
    [Abstract] [Full Text] [Related]

  • 4. New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies.
    Moon SW, Sun Y, Warther D, Huffman K, Freeman WR, Sailor MJ, Cheng L.
    Drug Deliv; 2018 Jan 01; 25(1):600-610. PubMed ID: 29461171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A sustained dual drug delivery system for proliferative vitreoretinopathy.
    Xiao Y, Choi KS, Warther D, Huffman K, Landeros S, Freeman WR, Sailor MJ, Cheng L.
    Drug Deliv; 2020 Dec 01; 27(1):1461-1473. PubMed ID: 33100053
    [Abstract] [Full Text] [Related]

  • 7. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N, Yoshizawa T, Nelson KD, Wilson CA.
    Invest Ophthalmol Vis Sci; 2000 May 01; 41(6):1561-9. PubMed ID: 10798677
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes.
    Chang-Lin JE, Burke JA, Peng Q, Lin T, Orilla WC, Ghosn CR, Zhang KM, Kuppermann BD, Robinson MR, Whitcup SM, Welty DF.
    Invest Ophthalmol Vis Sci; 2011 Jun 28; 52(7):4605-9. PubMed ID: 21421864
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyes.
    Bhagat R, Zhang J, Farooq S, Li XY.
    J Ocul Pharmacol Ther; 2014 Dec 28; 30(10):854-8. PubMed ID: 25411827
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system.
    Chhablani J, Nieto A, Hou H, Wu EC, Freeman WR, Sailor MJ, Cheng L.
    Invest Ophthalmol Vis Sci; 2013 Feb 01; 54(2):1268-79. PubMed ID: 23322571
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A sustained intravitreal drug delivery system with remote real time monitoring capability.
    Hou H, Nieto A, Belghith A, Nan K, Li Y, Freeman WR, Sailor MJ, Cheng L.
    Acta Biomater; 2015 Sep 01; 24():309-21. PubMed ID: 26087110
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
    Cheng CK, Berger AS, Pearson PA, Ashton P, Jaffe GJ.
    Invest Ophthalmol Vis Sci; 1995 Feb 01; 36(2):442-53. PubMed ID: 7843913
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF, Tsourdou A, Tzatzarakis MN, Tsika C, Charisis S, Naoumidi I, Plainis S, Tsilimbaris MK.
    J Ocul Pharmacol Ther; 2013 Sep 01; 29(7):627-32. PubMed ID: 23556534
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sustained release intravitreal dexamethasone.
    Hainsworth DP, Pearson PA, Conklin JD, Ashton P.
    J Ocul Pharmacol Ther; 1996 Sep 01; 12(1):57-63. PubMed ID: 8925398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.